Sheila Gujrathi's Net Worth

$12.7 Million

Estimate Recalculated Nov 8, 2024 04:39PM EST

Who is Sheila Gujrathi?

Sheila Gujrathi has an estimated net worth of $12.7 Million. This is based on reported shares across multiple companies, which include Turning Point Therapeutics, Inc., Receptos, Inc., Ventyx Biosciences, Inc., Gossamer Bio, Inc., Janux Therapeutics, Inc., and FIVE PRIME THERAPEUTICS INC.

SEC CIK

Sheila Gujrathi's CIK is 0001575202

Past Insider Trading and Trends

2024 was Sheila Gujrathi's most active year for acquiring shares with 5 total transactions. Sheila Gujrathi's most active month to acquire stocks was the month of May. 2015 was Sheila Gujrathi's most active year for disposing of shares, totalling 5 transactions. Sheila Gujrathi's most active month to dispose stocks was the month of July. 2023 saw Sheila Gujrathi paying a total of $603,000.00 for 128,437 shares, this is the most they've acquired in one year. In 2015 Sheila Gujrathi cashed out on 344,645 shares for a total of $44,119,054.22, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Turning Point Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Apr 22
Form 3
—
0
—
—
0
No matching records found

Receptos, Inc. No price found

Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-133.16K
—
—
0
Aug 25 - Aug 27
Form 4
+10.36%
12.5K
—
—
133.16K
Apr 1
Form 4
-19.91%
-30.00K
$108.99
-$3,269,700.00
120.66K
Scheduled
Nov 11
Form 4
-16.61%
-30.00K
$61.45
-$1,843,500.00
150.66K
Scheduled
Sep 22
Form 4
—
0
—
—
0
Apr 3
Form 4
—
0
—
—
0
Jul 17
Form 4
+7.97%
13.33K
$5.25
$69,998.25
180.66K
May 14
Form 3
—
0
—
—
0
No matching records found

Ventyx Biosciences, Inc. (VTYX) Snapshot price: $2.0801

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Jan 21
Form 4
—
0
—
—
0
Jun 8
Form 4/A
—
0
—
—
0
Jun 9
Form 4
—
0
$19.88
-$2,770,240.00
0
Mar 30
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Dec 2
Form 4
∞
32.9K
—
—
32.9K
Oct 25
Form 3
—
0
—
—
0
No matching records found

Gossamer Bio, Inc. (GOSS) Snapshot price: $0.9657

President & CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
189.5K
—
—
189.5K
Feb 14
Form 4
+0.25%
10K
$16.80
$167,980.00
4.05M
Sep 27
Form 4
—
0
—
—
0
Mar 25
Form 4
+1.56%
62.03K
—
—
4.04M
Feb 12
Form 3
—
0
—
—
0
No matching records found

Janux Therapeutics, Inc. (JANX) Snapshot price: $42.3

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+4.17%
4.61K
—
—
115.14K
Nov 5
Form 4
+2.31%
2.5K
—
—
110.53K
Jun 26
Form 4
+2.84%
2.99K
—
—
108.03K
Feb 29
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jun 14
Form 3
—
0
—
—
0
No matching records found